HBIO: Prakiraan rega marang bathi harvardbioscience.com

Harvard Bioscience creates a unique toolkit for global laboratories, facilitating cell research and drug synthesis. Production relies on ESG standards, waste minimization, and energy efficiency. Pricing policy is balanced by scientist loyalty and the cost-reduction needs of biotech startups. The company's forward P/E ratio clearly demonstrates market earnings expectations, where the 213.20 mark serves as a key metric.

HBIO - Kapitalisasi marang proyeksi bathi Harvard Bioscience, Inc. ing rentang 04.07.2022 - 11.11.2026

Rincian analitis lan laporan data perusahaan harvardbioscience.com (HBIO)

- nilai saham lan prakiraan konsensus rega:

Bagan rega Harvard Bioscience|HBIO - Bagan rega target

- informasi kapitalisasi pasar:

Biji pasar Harvard Bioscience Inc.|HBIO - Nilai Dipunlarasaken Utang lan Kas

- statistik nilai buku emiten:

Nilai Buku saben Saham Harvard Bioscience|HBIO - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku harvardbioscience.com|HBIO - Total Aset Bisnis

- indikator beban utang lan likuiditas:

Utang marang Ekuitas Harvard Bioscience|HBIO - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Harvard Bioscience, Inc.|HBIO - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Harvard Bioscience Inc.|HBIO - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Harvard Bioscience|Likuiditas cepet harvardbioscience.com

- statistik bathi lan rasio pasar:

HBIO - Penghasilan resik|Proyeksi bathi mangsa ngarep Harvard Bioscience|HBIO - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Harvard Bioscience|HBIO - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harvard Bioscience Inc.|HBIO - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Harvard Bioscience|HBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan harvardbioscience.com|HBIO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Harvard Bioscience

Ringkesan analisis perusahaan:HBIO Harvard Bioscience

Produk mawa merek Harvard Bioscience Inc.

Forward P/E measures a stock's market value relative to projected net income, allowing for an assessment of the premium paid for future earnings. Analyzing the forward P/E valuation of Harvard Bioscience (HBIO) helps determine entry points, given that the large-scale robotization of HBIO assembly lines and the implementation of computer vision systems should optimize costs, thereby fundamentally justifying profit growth and the asset's current value.

Pesaing langsung